Clinical Trials Directory

Trials / Completed

CompletedNCT01937663

A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
—
Sponsor
Kissei Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
20 Years
Healthy volunteers
—

Summary

The purpose of this study is to evaluate the efficacy and safety of tapered KWA-0711 dose in chronic constipation patients.

Conditions

Interventions

TypeNameDescription
DRUGKWA-0711

Timeline

Primary completion
2014-01-01
First posted
2013-09-09
Last updated
2014-11-13

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01937663. Inclusion in this directory is not an endorsement.

A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation (NCT01937663) · Clinical Trials Directory